Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome
- PMID: 28083040
- PMCID: PMC5216296
- DOI: 10.12669/pjms.326.11391
Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome
Abstract
Objective: To explore the effects of letrozole (LE) in combination with low-dose intramuscular injection of human menopausal gonadotropin (HMG) on the ovulation induction and pregnancy of patients with polycystic ovary syndrome (PCOS).
Methods: A total of 156 patients with PCOS infertility were randomly divided into an LE group, a clomiphene citrate (CC) group and an LE + HMG group (n= 52). LE and CC were orally taken according to the prescribed dosage on the 3rd-5th days of menstruation respectively, and 75 IU HMG was given through intramuscular injection. The ovulation induction parameters and pregnancy outcomes were observed.
Results: The number of ovulation cycle of LE + HMG group was significantly higher than that of LE group (χ2=8.451, P<0.001). After injection of human chorionic gonadotropin, both endometrial thickness and number of mature follicles of LE + HMG group were significantly higher than those of other two groups (P<0.001), and the daily estradiol (E2) level was also higher (q=4.531, P<0.05). The pregnancy rate of LE + HMG group was 55.7%, which exceeded those of other two groups (compared to LE group, χ2=4.012, P<0.05). In LE + HMG group, the average medication cycle of clinically pregnant patients was (2.9 ± 0.3) weeks, which was significantly shorter than those of CC and LE groups (F=17.241, P<0.001).
Conclusion: The regimen using LE in combination with low-dose intramuscular injection of HMG has satisfactory therapeutic effects on ovulation induction, short medication cycle and high clinical pregnancy rate, which is promising for treating patients with PCOS infertility.
Keywords: human menopausal gonadotropin; letrozole; ovulation; polycystic ovary syndrome; pregnancy.
Conflict of interest statement
Declaration of interest: None.
Similar articles
-
Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study.Medicine (Baltimore). 2020 Jan;99(4):e18383. doi: 10.1097/MD.0000000000018383. Medicine (Baltimore). 2020. PMID: 31977842 Free PMC article. Clinical Trial.
-
[Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].Sichuan Da Xue Xue Bao Yi Xue Ban. 2016 Nov;47(6):874-877. Sichuan Da Xue Xue Bao Yi Xue Ban. 2016. PMID: 28598116 Clinical Trial. Chinese.
-
Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.Drug Des Devel Ther. 2015 Nov 11;9:6001-8. doi: 10.2147/DDDT.S83259. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26648691 Free PMC article. Clinical Trial.
-
Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials.Arch Gynecol Obstet. 2018 May;297(5):1081-1088. doi: 10.1007/s00404-018-4688-6. Epub 2018 Feb 1. Arch Gynecol Obstet. 2018. PMID: 29392438
-
[Efficacy of acupuncture as adjunctive treatment on infertility patients with polycystic ovary syndrome].Zhongguo Zhen Jiu. 2018 Apr 12;38(4):358-61. doi: 10.13703/j.0255-2930.2018.04.004. Zhongguo Zhen Jiu. 2018. PMID: 29696918 Review. Chinese.
Cited by
-
The effect of mildly stimulated cycle versus artificial cycle on pregnancy outcomes in overweight/obese women with PCOS prior to frozen embryo transfer: a retrospective cohort study.BMC Pregnancy Childbirth. 2022 May 7;22(1):394. doi: 10.1186/s12884-022-04728-6. BMC Pregnancy Childbirth. 2022. PMID: 35525951 Free PMC article.
-
Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.Ther Adv Endocrinol Metab. 2022 Oct 7;13:20420188221127142. doi: 10.1177/20420188221127142. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 36225721 Free PMC article. Review.
-
The İmpact of Gonadotropin Type on Controlled Ovarian Stimulation and İntrauterine İnsemination Cycle Outcomes.J Hum Reprod Sci. 2022 Jan-Mar;15(1):51-57. doi: 10.4103/jhrs.jhrs_177_21. Epub 2022 Mar 31. J Hum Reprod Sci. 2022. PMID: 35494204 Free PMC article.
-
Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study.Medicine (Baltimore). 2020 Jan;99(4):e18383. doi: 10.1097/MD.0000000000018383. Medicine (Baltimore). 2020. PMID: 31977842 Free PMC article. Clinical Trial.
-
Effects of letrozole alone or in combination with gonadotropins on ovulation induction and clinical pregnancy in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized controlled trials.Hormones (Athens). 2024 Sep;23(3):497-508. doi: 10.1007/s42000-024-00531-4. Epub 2024 Jan 27. Hormones (Athens). 2024. PMID: 38280115
References
-
- Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333(13):853–861. - PubMed
-
- Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E. Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev. 2009;4:CD002249. - PubMed
-
- Casper RF, Mitwally MF. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol. 2011;54(4):685–695. doi:10.1097/GRF.0b013e3182353d0f. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources